Dawn B. Beaulieu

2.8k total citations
86 papers, 2.0k citations indexed

About

Dawn B. Beaulieu is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dawn B. Beaulieu has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 32 papers in Epidemiology and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dawn B. Beaulieu's work include Inflammatory Bowel Disease (52 papers), Microscopic Colitis (30 papers) and Pregnancy and Medication Impact (18 papers). Dawn B. Beaulieu is often cited by papers focused on Inflammatory Bowel Disease (52 papers), Microscopic Colitis (30 papers) and Pregnancy and Medication Impact (18 papers). Dawn B. Beaulieu collaborates with scholars based in United States and Canada. Dawn B. Beaulieu's co-authors include Sara Horst, David A. Schwartz, David G. Binion, Mazen Issa, Josh F. Knox, Mary F. Otterson, Jeanne Emmons, Ashwin N. Ananthakrishnan, Susan Skaros and Richard Komorowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Dawn B. Beaulieu

78 papers receiving 2.0k citations

Peers

Countries citing papers authored by Dawn B. Beaulieu

Since Specialization

Citations

This map shows the geographic impact of Dawn B. Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn B. Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn B. Beaulieu more than expected).

Fields of papers citing papers by Dawn B. Beaulieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn B. Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn B. Beaulieu. The network helps show where Dawn B. Beaulieu may publish in the future.

Co-authorship network of co-authors of Dawn B. Beaulieu

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn B. Beaulieu. A scholar is included among the top collaborators of Dawn B. Beaulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn B. Beaulieu. Dawn B. Beaulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mo1871 USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE 2024 ·Gastroenterology ·Millie D. Long, Sunanda V. Kane, Dawn B. Beaulieu, Bincy Abraham, Xian Zhang, Uma Mahadevan	4
2	NON-INVASIVE DETERMINATION OF DISEASE ACTIVITY IN CROHN’S DISEASE BY SERUM LUMINEX PROFILING 2024 ·Inflammatory Bowel Diseases ·(unknown), (unknown), (unknown), Margaret M. Allaman, Dawn B. Beaulieu, Robin Dalal, Baldeep Pabla, Elizabeth Scoville, Sara Horst, David A. Schwartz, Keith T. Wilson, Lori A. Coburn	1
3	Multicenter Study of Nonadherence to Self-Injectable Biologic Therapy in Patients With Inflammatory Bowel Disease: Risk Factors and Outcomes 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Nisha Shah, James C. Slaughter, (unknown), Autumn D. Zuckerman, (unknown), Elizabeth Scoville, Robin Dalal, Dawn B. Beaulieu, Baldeep Pabla, David A. Schwartz, (unknown), Byron P. Vaughn, Sara Horst	0
4	Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience 2021 ·Digestive Diseases and Sciences ·Baldeep Pabla, (unknown), James C. Slaughter, Elizabeth Scoville, Robin Dalal, Dawn B. Beaulieu, David A. Schwartz, Sara Horst	11
5	Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study 2021 ·Digestive Diseases and Sciences ·(unknown), David A. Schwartz, Robin Dalal, Sara Horst, Elizabeth Scoville, Dawn W. Adams, Dawn B. Beaulieu, James C. Slaughter, Tina Higginbotham, Michael F. Vaezi, Yash A. Choksi	2
6	Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease 2021 ·Clinical Pharmacokinetics ·Wan Sun, Blair Fennimore, Dawn B. Beaulieu, Razvan Arsenescu, Adam C. Stein, Jingjing Chen, Tiffany Lin, (unknown), (unknown), Maria Rosario, Richard A. Lirio	9
7	Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy 2019 ·Digestive Diseases and Sciences ·(unknown), Ameer Abutaleb, (unknown), Patricia Langenberg, Miguel Regueiro, David A. Schwartz, J. Kathleen Tracy, Leyla Ghazi, Seema Patil, Sandra Quezada, (unknown), Charlene C. Quinn, Guruprasad Jambaulikar, Dawn B. Beaulieu, Sara Horst, Raymond K. Cross	28
8	Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn’s Disease 2019 ·Scientific Reports ·Elizabeth Scoville, Margaret M. Allaman, Dawn W. Adams, Amy K. Motley, (unknown), Sarah L. Ferguson, Sara Horst, Christopher S. Williams, Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson, Lori A. Coburn	45
9	Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery 2017 ·Inflammatory Bowel Diseases ·Dawn W. Adams, Shelly Gurwara, Heidi J. Silver, Sara Horst, Dawn B. Beaulieu, David A. Schwartz, Douglas L. Seidner	107
10	Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease 2017 ·Digestive Diseases and Sciences ·(unknown), Robin Dalal, Dawn B. Beaulieu, (unknown), (unknown), Lawrence S. Gaines, (unknown), David A. Schwartz, Sara Horst	21
11	Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines 2017 ·Clinical Gastroenterology and Hepatology ·Dawn B. Beaulieu, Ashwin N. Ananthakrishnan, Christopher F. Martin, Russell D. Cohen, Sunanda V. Kane, Uma Mahadevan	93
12	Clinical characterization of in vivo inflammatory bowel disease with Raman spectroscopy 2017 ·Biomedical Optics Express ·Isaac J. Pence, Dawn B. Beaulieu, Sara Horst, Xiaohong Bi, Alan J. Herline, David A. Schwartz, Anita Mahadevan‐Jansen	42
13	Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling 2017 ·Metabolomics ·Elizabeth Scoville, Margaret M. Allaman, Caroline T. Brown, Amy K. Motley, Sara Horst, Christopher S. Williams, Tatsuki Koyama, Zhiguo Zhao, Dawn W. Adams, Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson, Lori A. Coburn	147
14	L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis 2016 ·Inflammatory Bowel Diseases ·Lori A. Coburn, Sara Horst, Margaret M. Allaman, Caroline T. Brown, Christopher S. Williams, (unknown), (unknown), Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson	64
15	Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab 2016 ·Inflammatory Bowel Diseases ·Kimberly A. Harris, Sara N. Horst, (unknown), (unknown), (unknown), (unknown), Dawn B. Beaulieu, Leyla Ghazi, David A. Schwartz	67
16	Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy 2016 ·Journal of the Pediatric Infectious Diseases Society ·James G. Carlucci, Natasha Halasa, C. Buddy Creech, Daniel E. Dulek, Oscar G. Gómez‐Duarte, George E. Nelson, H. Keipp Talbot, (unknown), (unknown), Uma Mahadevan, Dawn B. Beaulieu	5
17	Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments 2015 ·Inflammatory Bowel Diseases ·(unknown), Dawn B. Beaulieu, Sara Horst, (unknown), (unknown), (unknown), David A. Schwartz	13
18	Inflammatory bowel disease in pregnancy 2011 ·World Journal of Gastroenterology ·Dawn B. Beaulieu	58
19	Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? 2009 ·Inflammatory Bowel Diseases ·Ashwin N. Ananthakrishnan, Dawn B. Beaulieu, Alex Ulitsky, Yelena Zadvornova, Sue Skaros, Kathryn Johnson, Amar S. Naik, Lilani P. Perera, Mazen Issa, David G. Binion, Kia Saeian	27
20	Durability of infliximab in Crohnʼs disease 2009 ·Inflammatory Bowel Diseases ·(unknown), Ashwin N. Ananthakrishnan, Mazen Issa, Dawn B. Beaulieu, Sue Skaros, Yelena Zadvornova, Kathryn Johnson, Mary F. Otterson, David G. Binion	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact